ACH token remains extremely bearish as Alchemy Chain expands its supply
Alchemy Pay’s ACH token has been under heavy pressure in recent weeks. Since late January, the token has been locked in a relentless
Economy
Economy
Interview: Crypto natives tired of token manipulation, says Ostium CEO
As interest in tokenised real-world assets and on-chain derivatives has grown, Ostium has emerged as a significant participant in the segment. The platform
Economy
Jamie Dimon warns credit cycle risks echo pre-2008 lending boom
JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon said growing competitive pressures across finance are beginning to resemble conditions that preceded the
Economy
Salesforce stock has become cheap: will it rebound after earnings?
Salesforce’s stock price continued its strong downward trend this week, reaching its lowest level since March 2023. CRM dropped to $178, down by
Gold
Why is Arcellx stock up 80% today? Gilead’s $7.8B answer
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
Gold
South Korea debates bank control over won stablecoins
South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within
Gold
Finland’s IQM leads Europe’s quantum push with US listing plan
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.
Gold
We predicted Blue Owl stock price crash: what’s next?
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.
Gold
Trump tariffs repriced after SCOTUS ruling: winners and losers
Fridays used to be reserved for routine headlines. But since Donald Trump’s reelection, every Friday seems like a bombshell day. And last Friday
Gold
Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its